Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 893-897

  Salinas Santander, Mauricio ^a   Díaz García, Daniel ^b   Rojas Martínez, Augusto ^a   Cantú Salinas, Cristina ^c   Sánchez Domínguez, Celia ^a   Reyes López, Miguel ^d   Cerda Flores, Ricardo M ^a   Ocampo Candiani, Jorge ^c   Ortiz López, Rocío ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Molecular Biology   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d NONE   (Mexico)

Author keywords

Active vitiligo vulgaris; Autoimmune diseases; Northeastern Mexican population; PCR RFLP; Tumor necrosis factor 308G A polymorphism

Indexed keywords

ALANINE; GENOMIC DNA; GLYCINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROMOTER REGION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VITILIGO; VITILIGO VULGARIS;

EID: 84858650341     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.508     Document Type: Article

References (19)

1. Gauthier Y, Cario Andre M and Taïeb A: A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16: 322-332, 2003.
2. Halder RM and Chappell JL: Vitiligo update. Semin Cutan Med Surg 28: 86-92, 2009.
3. Shajil EM, Chatterjee S, Agrawal D, Bagchi T and Begum R: Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 44: 526-539, 2006.
4. Zhu BC, Gao JG, Qu A, et al: title typecontributorA family history of vitiligo with autosomal dominant inheritance/title. title typejournalYi Chuan/title 24: 254-256, 2002 (In Chinese).
5. Parsad D, Dogra S and Kanwar AJ: Quality of life in patients with vitiligo. Health Qual Life Outcomes 1: 58, 2003.
6. Spritz RA: The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20: 271-278, 2007.
7. Tazi-Ahnini R, McDonagh AJ, Wengraf DA, et al: The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol 159: 591-596, 2008.
8. Rudle N: Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol 4: 327-332, 1992.
9. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D and Strominger JL: Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83: 8699-8702, 1986.
10. Liz-Grana M and Gomez-Reino Carnota JJ: Tumor necrosis factor. Genetics, cell action mechanism and involvement in inflammation. Alergol Inmunol Clin 16: 140-149, 2001.
11. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Rodríguez-Pérez JM, Zuñiga J and Granados J: Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett 95: 31-35, 2004.
12. Vargas-Alarcón G, Casasola-Vargas J, Rodríguez-Pérez JM, Huerta-Sil G, Pérez-Hernández N, Londoño J, Pacheco-Tena C, Cardiel MH, Granados J and Burgos-Vargas R: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67: 826-832, 2006.
13. Sánchez-Domínguez CN, Buenfil-Lozano JA, Molina-Guajardo CA, Borjas-Almaguer OD, Castillo-Lartigue A, Bustamante-Sáenz A, Martínez-Rodríguez HG, Alarcón MA, Reyes-López MA and Ortiz-López R: Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha -308 promoter polymorphism in northeastern Mexico. Allergy Asthma Proc 29: 406-410, 2008.
14. Hernández-Pacheco G, Flores-Domínguez C, Rodríguez-Pérez JM, Pérez-Hernández N, Fragoso JM, Saul A, Alvarez-León E, Granados J, Reyes PA and Vargas-Alarcón G: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21: 59-63, 2003.
15. Martínez-Ríos MA, Peña-Duque MA, Fragoso JM, Delgadillo-Rodríguez H, Rodríguez-Pérez JM, Miranda-Malpica E, Cruz-Robles D, Cavazos-Quero MM, Rodríguez-Lobato LG and Vargas-Alarcón G: Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting. Biochem Genet: Jul 8, 2009 (E-pub ahead of print).
16. Namian AM, Shahbaz S, Salmanpoor R, Namazi MR, Dehghani F and Kamali-Sarvestani E: Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res 301: 21-25, 2009.
17. Yazici AC, Erdal ME, Kaya TI, Ikizoglu G, Savasoglu K, Camdeviren H and Tursen U: Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo. Arch Dermatol Res 298: 46-49, 2006.
18. Chen YP, Pfab T, Slowinski T, Richter CM, Godes M and Hocher B: Impact of genetic variation of tumor necrosis factor-α on gestational hypertension. Chin Med J (Engl) 119: 719-724, 2006.
19. Huang CL, Nordlund JJ and Boissy R: Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 3: 301-308, 2002.